Darren Liang specializes in inbound and outbound capital markets, mergers & acquisitions of listed companies, venture capital, and private equity transactions. His practice covers a wide range of industries, including integrated circuits and semiconductors, life sciences and healthcare, artificial intelligence, intelligent manufacturing, corporate services (SaaS), high-tech, internet, e-commerce, new retail, and cultural entertainment.
He has provided legal services on many influential deals, including: Shanghai MicroPort EP MedTech Co.'s (688351) Shanghai IPO; the A-share listings of Thinker Agricultural Machinery and Hongxin Electronics Technology; JD Logistics Inc.'s acquisition (by indirect acquisition through agreements and comprehensive tender offer) of Deppon Logistics Co., Ltd.; representing Blue Sail Medical (002382) in the red-chip restructuring of its cardiovascular and cerebrovascular business; and JD Group's acquisition of shares in multiple A-share listed companies.
Darren has been recognized by several legal rating organizations, including: Asian Legal Business (ALB) as one of the 'Yangtze River Delta Rising Lawyers' listed in the 2022 China Regional Ranking; China Business Law Journal as an outstanding lawyer of 'The A-List' in 2019, 2021, and 2022; LEGALBAND as one of the 'Top 15 Rising Partners' in 2021, 'Top Ranked Lawyers - Capital Markets' from 2020 to 2023, and one of the 'China Top 30 Most Outstanding Lawyers' in 2016; DAWKINS as one of the 'Top Ranked Lawyers' listed in the 'Domestic Listing' category; and Interface News as one of the 'Interface Top 100 Lawyers' in 2020. He is also qualified as an independent director of an A-share listed company.
